Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Disease

Why Mereo BioPharma Shares Are Jumping Today

AstraZeneca plc (NASDAQ:AZN) is rumored to be eyeing take over of Mereo BioPharma Group plc (NASDAQ:MREO), according to a report in The Times. The Times' report says that "Mereo would accept $5, equating to $500 million including American depositary receipts or ADRs. Evercore and Citigroup are said to be involved as advisers." Mereo's lead…

Benzinga

FDA clears Moderna, Pfizer COVID shots for children 5 and under

COVID vaccines for children ages 5 and under from Pfizer Inc. and Moderna Inc. received authorization from U.S. regulators, meaning almost all of the American population can soon get protected against COVID-19 disease.

Tribune News Service

Woman died after hospital fed her Weetabix as son's 'heart sank' at tragic news

Hazel Pearson, 80, who suffered from coeliac disease, was violently sick after she was fed Weetabix at Wrexham Maelor Hospital, Wales, and died just four days later, an inquest heard

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

Healthy and happy diet for kids: Foods to build their immunity

We all want our kids to get the right nutrition for their growth and development and to have a strong immune system. It is essential to monitor what they eat and make sure that we feed them nourishing food. However, kids are mostly attracted to junk food that can do…

The Times of India

4,000 women with breast cancer could benefit from new pill taken twice a day

Abemaciclib is a twice-daily pill that is used with hormone therapy

Evening Standard

Emmerdale's Danny Miller to support Rob Burrow with star-studded celeb event

There's an ongoing campaign to build The Rob Burrow Centre for Motor Neurone Disease

Leeds Live

Addex Stops Parkinson's-Associated Dyskinesia Trial - Read Here Why

Addex Therapeutics Ltd (NASDAQ:ADXN) has terminated the Phase 2b/3 study of dipraglurant for dyskinesia associated with Parkinson's disease (PD-LID) due to the slow recruitment of patients. Data readout from the trial was expected in 1H of 2023. The company attributes this to the consequences of COVID-19-related patient concerns about participation in studies, staffing…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Auchterarder's Sarah Mitchell determined to help others after losing mum to Huntington’s disease

The Perth College UHI student has joined Scottish Huntington’s Association as a volunteer youth ambassador to support other young people

Daily Record

Mayo Clinic Q and A: Tick-borne illnesses

DEAR MAYO CLINIC: A close friend was diagnosed recently with Lyme disease due to a tick bite. However, I recently read about some new type of tick-borne illness. My family loves to hike and be outdoors, but I'm nervous now about continuing our activities. How can I reduce our risk…

Tribune News Service

RTE legend Charlie Bird 'upset and guilty' as he struggles to respond to hundreds letters of support

The 72-year-old who is battling Motor Neurone Disease said he doesn't have the "time and the energy" to respond to everyone

Irish Mirror

Hospital funding deal sets a tight deadline for real reform, and the clock's ticking

At the urging of the premiers, Prime Minister Anthony Albanese on Friday agreed to extend current public hospital funding until the end of the year.

The Conversation

Thousands of women with breast cancer could benefit from new NHS-approved pill

A clinical trial found that people taking the drug alongside hormone therapy had a more than 30% better chance of their cancer not coming back

Daily Mirror

NHS to offer women in England drug that cuts recurrence of breast cancer

Abemaciclib can improve chances of certain type of cancer not returning after surgery by more than 30%

The Guardian - UK

N.Korea sends aid to 800 families suffering from intestinal epidemic

North Korean leader Kim Jong Un and other senior officials prepared aid to send to 800 families suffering from an unidentified intestinal epidemic, state media reported on Friday, as the country also battles its first COVID-19 outbreak.

Reuters

Get all your
news in one place.

100's of premium titles.
One news app.

ABC News

Strawberry prices soar after wet weather, disease impact winter crops

First it was lettuce, now strawberries are being sold for staggering prices, with a Canberra supermarket asking $11.99 for a 250g punnet.

The Independent UK

About 4,000 women with breast cancer could benefit from new twice-daily pill

The drug, made by Eli Lilly, is suitable for those with hormone receptor-positive, HER2-negative, node-positive early breast cancer.

The Independent UK

New NHS breast cancer pill can cut recurrence of disease

The twice-daily pill reduces the risk of cancer returning once a tumour has been removed

Wales Online

Thousands to benefit after drug is approved for post-surgery breast cancer patients

The twice-daily pill makes it up to 30 per cent more likely that disease will not return

Get all your
news in one place.

100's of premium titles.
One news app.

Daily Record

Certain health conditions can double your dementia risk, warns new study

And another study has been published linking dementia with vitamin D levels.

ABC News

How climate change could be exacerbating the spread of diseases like monkeypox and Japanese encephalitis

A new study predicts the changing climate will provide increased opportunities for the spread of novel viruses.

Benzinga

HC Wainwright Sees Opportunity For Acadia's Alzheimer's Candidate

HC Wainwright says FDA's briefing document on ACADIA Pharmaceuticals Inc's (NASDAQ: ACAD) pimavanserin was not unexpected.

The Hindu

Is COVID-19 becoming endemic?

There are indications, but endemicity seems to be a little further away

The Hindu

Karnataka among two States to host One Health pilot with focus on zoonotic diseases

Learnings from the pilot, to be launched in the State on June 28, will be used to develop a national One Health Framework

Benzinga

More Patent Applications For Psilocybin: Learn About NOVA's Psychedelic Treatments For Neurological Diseases

The Canadian biotech company Nova Mentis Life Science Corp. (OTCQB: NMLSF) is filing new provisional patent applications to the U.S.

AAP

Shoddy homes lethal to Indigenous patients

Excessive heat, poor housing, energy insecurity and chronic disease have reached critical levels in remote Indigenous communities in the Northern Territory.

1 … 596 597 598 599

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Australian National University

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.